SCHEMBL873052

SCHEMBL873052

N#Cc1ccccc1-c1cccc(C=CC(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.49
HDAC6 Q9UBN7 2/20 0.49
HDAC3 O15379 1/20 0.49
TNKS O95271 1/20 0.49
HDAC4 P56524 1/20 0.49
HCAR2 Q8TDS4 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
TNKS2 Q9H2K2 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
NPSR1 Q6W5P4 1/20 0.48
SLC22A12 Q96S37 1/20 0.47
PIM2 Q9P1W9 1/20 0.47
ALDH1A1 P00352 3/20 0.46
RXRA P19793 1/20 0.44
NR4A2 P43354 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8415412 0.88 ESR2 (0.42) HDAC1HDAC6HDAC2HDAC8NPSR1
SCHEMBL690414 0.84 ESR2 (0.54) HDAC1HDAC6HDAC3TNKSHDAC4
SCHEMBL30584137 0.78 HDAC2 (0.67) HDAC1HDAC6HDAC3TNKSHDAC4
SCHEMBL414597 0.78 HDAC2 (0.67) HDAC1HDAC6HDAC3TNKSHDAC4
SCHEMBL414598 0.78 HDAC2 (0.67) HDAC1HDAC6HDAC3TNKSHDAC4
SCHEMBL1510133 0.78 HDAC1 (0.53) HDAC1HDAC6HDAC3TNKSHDAC4
SCHEMBL31325636 0.78 ESR2 (0.42) HDAC1HDAC6HDAC3TNKSHDAC4
SCHEMBL1510134 0.78 HDAC1 (0.53) HDAC1HDAC6HDAC3TNKSHDAC4
SCHEMBL5208060 0.78 HDAC3 (0.53) HDAC1HDAC6HDAC3TNKSHDAC4
SCHEMBL1510136 0.78 HDAC3 (0.53) HDAC1HDAC6HDAC3TNKSHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4340807-A1 HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS Lubrizol Advanced Materials, Inc. (US) 2024-03-27 EP disclosed
US-20210154120-A1 HAIR MODIFICATION COMPOSITION AND METHOD THEREFOR LUBRIZOL ADVANCED MATERIALS, INC. (US) 2021-05-27 US disclosed
EP-3773458-A1 HAIR MODIFICATION COMPOSITION AND METHOD THEREFOR Lubrizol Advanced Materials, Inc. (US) 2021-02-17 EP disclosed
US-10758490-B2 Nanocapsules containing microemulsions LIPOTEC, S.A. (ES) 2020-09-01 US disclosed
WO-2019200027-A1 HAIR MODIFICATION COMPOSITION AND METHOD THEREFOR LUBRIZOL ADVANCED MATERIALS, INC. (US) 2019-10-17 WO disclosed
EP-2618926-B1 NANOCAPSULES CONTAINING MICROEMULSIONS LIPOTEC SA (ES) 2019-05-08 EP disclosed
EP-2536815-B1 USE OF LIPOSOMES FOR THE TREATMENT OF TEXTILE MATERIALS LIPOTEC SA (ES) 2018-07-11 EP disclosed
EP-3272398-A1 LIPID NANOPARTICLE CAPSULES Lipotec S.A. (ES) 2018-01-24 EP disclosed
US-9717659-B2 Liposomes for the treatment of textile materials LIPOTEC, S.A. (ES) 2017-08-01 US disclosed
US-9708757-B2 Process of treatment of fibers and/or textile materials LIPOTEC, S.A. (ES) 2017-07-18 US disclosed
WO-2011101153-A9 LIPOSOMES FOR THE TREATMENT OF TEXTILE MATERIALS LIPOTEC, S.A. (ES) 2013-03-14 WO disclosed
US-20130064876-A1 PROCESS OF TREATMENT OF FIBERS AND/OR TEXTILE MATERIALS LIPOTEC S.A. (ES) 2013-03-14 US disclosed
EP-2550391-A1 PROCESS OF TREATMENT OF FIBERS AND/OR TEXTILE MATERIALS Lipotec, S.A. (ES) 2013-01-30 EP disclosed
EP-2549977-A2 LIPID NANOPARTICLE CAPSULES Lipotec, S.A. (ES) 2013-01-30 EP disclosed
US-20130017239-A1 LIPID NANOPARTICLE CAPSULES LIPOTEC S.A. (ES) 2013-01-17 US disclosed
EP-2536815-A1 LIPOSOMES FOR THE TREATMENT OF TEXTILE MATERIALS Lipotec, S.A. (ES) 2012-12-26 EP disclosed
WO-2012038061-A2 NANOCAPSULES CONTAINING MICROEMULSIONS LIPOTEC, S.A. (ES) 2012-03-29 WO disclosed
WO-2011116963-A2 LIPID NANOPARTICLE CAPSULES LIPOTEC S.A. (ES) 2011-09-29 WO disclosed
WO-2011116962-A1 PROCESS OF TREATMENT OF FIBERS AND/OR TEXTILE MATERIALS LIPOTEC S.A. (ES) 2011-09-29 WO disclosed
WO-2011101153-A1 LIPOSOMES FOR THE TREATMENT OF TEXTILE MATERIALS LIPOTEC, S.A. (ES) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210154120-A1 HAIR MODIFICATION COMPOSITION AND METHOD THEREFOR DSC1, HADHB, PHOSPHO1 HDAC1 281/4885HDAC6 2965/4885HDAC3 2606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.